PRIMARY CNS LYMPHOMA (PCNSL)
Clinical trials for PRIMARY CNS LYMPHOMA (PCNSL) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY CNS LYMPHOMA (PCNSL) trials appear
Sign up with your email to follow new studies for PRIMARY CNS LYMPHOMA (PCNSL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hard-to-treat brain lymphoma: cell therapy trial launches
Disease control Recruiting nowThis study tests a new treatment called Anbal-cabtagene autoleucel (Anbal-cel) for people with a type of lymphoma that affects the brain or spinal cord and has not responded to standard therapy or has returned. The treatment uses a patient's own immune cells, which are collected,…
Matched conditions: PRIMARY CNS LYMPHOMA (PCNSL)
Phase: PHASE2 • Sponsor: Hyungwoo Cho • Aim: Disease control
Last updated May 26, 2026 08:21 UTC
-
New hope for hard-to-treat brain cancer: combo therapy enters human trials
Disease control Recruiting nowThis study tests a new drug called epcoritamab, given with two other drugs (lenalidomide and rituximab), for people whose primary CNS lymphoma has returned or stopped responding to treatment. About 60 adults will take part to see if the combination shrinks tumors and how safe it …
Matched conditions: PRIMARY CNS LYMPHOMA (PCNSL)
Phase: PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated May 26, 2026 08:17 UTC